Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
3D Medicines, Inc. (HK:1244)
:1244
Holding HK:1244?
Track your performance easily
1244 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$1.60 - HK$8.38
Previous CloseN/A
Volume120.00K
Average Volume (3M)810.36K
Market Cap
HK$803.02M
Enterprise ValueHK$539.33M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.73
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.08
Shares Outstanding258,207,000
10 Day Avg. Volume281,750
30 Day Avg. Volume810,359
Standard Deviation0.31
R-Squared0.12
Alpha-0.06
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
3D Medicines, Inc. News
PremiumCompany Announcements
3D Medicines Inc. Shifts Focus to NSCLC Trial
PremiumCompany Announcements
3D Medicines Executives Bolster Shareholdings
PremiumCompany Announcements
3D Medicines Inc. Allocates Global Offering Proceeds
PremiumCompany Announcements
3D Medicines Inc. Faces Sharp Revenue DeclinePremiumCompany Announcements
3D Medicines Inc. Board Meeting Key for Investors
PremiumCompany Announcements
3D Medicines Inc. Unveils New Chinese NamePremiumCompany Announcements
3D Medicines Inc. Shareholders Approve All AGM Resolutions
PremiumCompany Announcements
3D Medicines Inc. Prepares for Key Annual MeetingOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.02%
Mutual Funds
― Other Institutional Investors
99.98% Public Companies and
Individual Investors
1244 FAQ
What was 3D Medicines, Inc.’s price range in the past 12 months?
3D Medicines, Inc. lowest stock price was HK$1.60 and its highest was HK$8.38 in the past 12 months.
What is 3D Medicines, Inc.’s market cap?
3D Medicines, Inc.’s market cap is HK$803.02M.
When is 3D Medicines, Inc.’s upcoming earnings report date?
3D Medicines, Inc.’s upcoming earnings report date is Mar 27, 2025 which is in 66 days.
How were 3D Medicines, Inc.’s earnings last quarter?
3D Medicines, Inc. released its earnings results on Aug 30, 2024. The company reported -HK$0.458 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.458.
Is 3D Medicines, Inc. overvalued?
According to Wall Street analysts 3D Medicines, Inc.’s price is currently Overvalued.
Does 3D Medicines, Inc. pay dividends?
3D Medicines, Inc. does not currently pay dividends.
What is 3D Medicines, Inc.’s EPS estimate?
3D Medicines, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does 3D Medicines, Inc. have?
3D Medicines, Inc. has 258,207,000 shares outstanding.
What happened to 3D Medicines, Inc.’s price movement after its last earnings report?
3D Medicines, Inc. reported an EPS of -HK$0.458 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.844%.
Which hedge fund is a major shareholder of 3D Medicines, Inc.?
Currently, no hedge funds are holding shares in HK:1244
---
3D Medicines, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.08%
12-Months-Change
Fundamentals
Return on Equity
-52.40%
Trailing 12-Months
Asset Growth
-6.52%
Trailing 12-Months
Technical Analysis
Lai Si Enterprise Holding Ltd.
―
CARsgen Therapeutics Holdings Ltd.
―
Newlink Technology Inc.
―
RemeGen Co. Ltd. Class H
―
---